Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Aktuálna cena Moderna Inc na trhu je 230,33 € s 24-hodinovým objemom obchodovania 3,56B €. Trhová kapitalizácia aktíva je 91,95B € po pohybe o 5.27% za posledný deň.
Tokenizovaný Moderna Inc sa obchoduje za 230,18 €, s tokenizovanou trhovou kapitalizáciou 2,31M € a 24-hodinovým objemom obchodovania 30,19M €. Tokenizované aktívum zaznamenalo zmenu o -27.76% za posledných 24 hodín.